Dr. Belle’s lab aims to unravel the mechanisms behind intestinal mucosal inflammation to elucidate the interactions between pathways and cells involved in intestinal mucosal damage and repair and apply them to the development of novel therapeutics.
The ElinavLab studies the interactions between the mammalian host and its microbiome to uncover effects on health and disease. They harness experimental biology, human trials and big data analyses to devise microbiome-based personalized medicine.
The Colonna lab is broadly interested in innate immunity, focused in two main areas related to IBD: 1) innate lymphoid cells in mucosal immunity and 2) plasmacytoid dendritic cells and IFNalpha/beta in host defense and autoimmunity.
The Choi lab studies the immune system and brain interaction, and its effects on neurodevelopment, behavior and mood. They seek to learn how cytokines may act as neuromodulators influencing the development and activity of neurons in the cortex.
The Chiu lab combines immunology, neurobiology and microbiology to investigate how bacteria interact with nociceptors to produce pain, and how these neurons modulate the immune response during inflammation.
Dr. Barton’s group studies innate immunity with the goal of understanding strategies of pathogen recognition and self/non-self discrimination to reveal critical balance points with fundamental implications for our understanding of immunity.
